Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis.

MLA

Gordon, Morris, et al. “Tacrolimus (FK506) for Induction of Remission in Corticosteroid-Refractory Ulcerative Colitis.” The Cochrane Database of Systematic Reviews, vol. 4, Apr. 2022, p. CD007216. EBSCOhost, https://doi.org/10.1002/14651858.CD007216.pub2.

APA

Gordon, M., Sinopoulou, V., Akobeng, A. K., Pana, M., Gasiea, R., & Moran, G. W. (2022). Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis. The Cochrane Database of Systematic Reviews, 4, CD007216. https://doi.org/10.1002/14651858.CD007216.pub2

Chicago

Gordon, Morris, Vassiliki Sinopoulou, Anthony K Akobeng, Mirela Pana, Rehab Gasiea, and Gordon William Moran. 2022. “Tacrolimus (FK506) for Induction of Remission in Corticosteroid-Refractory Ulcerative Colitis.” The Cochrane Database of Systematic Reviews 4 (April): CD007216. doi:10.1002/14651858.CD007216.pub2.